Evidence map›Paper›PMID 24637877›Full record

ArticlePloS one2014

DNA-damage foci to detect and characterize DNA repair alterations in children treated for pediatric malignancies.

Nadine Schuler, Jan Palm, Mareike Kaiser, Dominik Betten, Rhoikos Furtwängler, Christian Rübe, Norbert Graf, Claudia E Rübe

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways.Clinical cancer research : an official journal of the American Association for Cancer Research · 2015
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Nadine SchulerDepartment of Radiation Oncology, Saarland University, Homburg/Saar, Germany.
Jan PalmDepartment of Radiation Oncology, Saarland University, Homburg/Saar, Germany.
Mareike KaiserDepartment of Radiation Oncology, Saarland University, Homburg/Saar, Germany.
Dominik BettenDepartment of Radiation Oncology, Saarland University, Homburg/Saar, Germany.
Rhoikos FurtwänglerDepartment of Pediatric Hematology and Oncology, Saarland University, Homburg/Saar, Germany.
Christian RübeDepartment of Radiation Oncology, Saarland University, Homburg/Saar, Germany.
Norbert GrafDepartment of Pediatric Hematology and Oncology, Saarland University, Homburg/Saar, Germany.
Claudia E RübeDepartment of Radiation Oncology, Saarland University, Homburg/Saar, Germany.
Saarland University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn children diagnosed with cancer, we evaluated the DNA damage foci approach to identify patients with double-strand break (DSB) repair deficiencies, who may overreact to DNA-damaging radio- and chemotherapy. In one patient with Fanconi anemia (FA) suffering relapsing squamous cell carcinomas of the oral cavity we also characterized the repair defect in biopsies of skin, mucosa and tumor. METHODS AND MATERIALS: In children with histologically confirmed tumors or leukemias and healthy control-children DSB repair was investigated by counting γH2AX-, 53BP1- and pATM-foci in blood lymphocytes at defined time points after ex-vivo irradiation. This DSB repair capacity was correlated with treatment-related normal-tissue responses. For the FA patient the defective repair was also characterized in tissue biopsies by analyzing DNA damage response proteins by light and electron microscopy.

resultsBetween tumor-children and healthy control-children we observed significant differences in mean DSB repair capacity, suggesting that childhood cancer is based on genetic alterations affecting DNA repair. Only 1 out of 4 patients with grade-4 normal-tissue toxicities revealed an impaired DSB repair capacity. The defective DNA repair in FA patient was verified in irradiated blood lymphocytes as well as in non-irradiated mucosa and skin biopsies leading to an excessive accumulation of heterochromatin-associated DSBs in rapidly cycling cells.

conclusionsAnalyzing human tissues we show that DSB repair alterations predispose to cancer formation at younger ages and affect the susceptibility to normal-tissue toxicities. DNA damage foci analysis of blood and tissue samples allows one to detect and characterize DSB repair deficiencies and enables identification of patients at risk for high-grade toxicities. However, not all treatment-associated normal-tissue toxicities can be explained by DSB repair deficiencies.

Indexed as

DNA Breaks, Double-StrandedDNA RepairAdolescentAtaxia Telangiectasia Mutated ProteinsBiopsyBrainChildChild, PreschoolFemaleHeterozygoteHomozygoteHumansInfantLymphocytesMagnetic Resonance ImagingMaleAtaxia Telangiectasia Mutated Proteins

Identifiers

PMID24637877
PMCPMC3956609
OpenAlexW2075158658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.